submitted on 2024-03-19, 07:06 and posted on 2024-03-19, 07:06authored byDevendra Bansal, Praveen K. Bharti, Anushree Acharya, Mohamed H Abdelraheem, Priyanka Patel, Ashraf Elmalik, Salem Abosalah, Fahmi Y. Khan, Mohamed ElKhalifa, Hargobinder Kaur, Elmoubasher Farag, Nilanju P Sarmah, Pradyumna K. Mohapatra, Rakesh Sehgal, Jagadish Mahanta, Ali A. Sultan
<p dir="ltr">Malaria remains a significant public health challenge and is of global importance. Imported malaria is a growing problem in non-endemic areas throughout the world and also in Qatar due to a massive influx of migrants from endemic countries. Antimalarial drug resistance is an important deterrent in our fight against malaria today. Molecular markers mirror intrinsic antimalarial drug resistance and their changes precede clinical resistance. Thus, in the present study, molecular markers of sulphadoxine-pyrimethamine (<i>Pfdhfr</i> and <i>Pfdhps</i>) and artemisinin (<i>PfATPase6</i> and <i>Pfk13</i>) were sequenced to determine the drug resistance genotypes among 118 imported <i>P. falciparum</i> isolates in Qatar, between 2013 and 2016. All the isolates had mutant <i>Pfdhfr</i> alleles, with either double mutant (51I/108N) (59.3%) or triple mutant (51I, 59R and 108N) (30.6%) genotypes. I164L substitution was not found in this study. In case of <i>Pfdhps</i>, majority of the samples were carriers of either single (S436A/ A437G/ K540E) mutant (47.2%) or double (S436A/K540E, A437G/K540E, K540E/A581G) mutant (39.8%). A single novel point mutation (431V) was observed in the samples originated from Nigeria and Ghana. Polymorphisms in <i>PfATPase6</i> were absent and only one non-synonymous mutation in <i>Pfk13</i> was found at codon G453A from a sample of Kenyan origin. High levels of sulphadoxine-pyrimethamine resistance in the present study provide potential information about the spread of antimalarial drug resistance and will be beneficial for the treatment of imported malaria cases in Qatar.</p><h2>Other Information</h2><p dir="ltr">Published in: Pathogens and Global Health<br>License: <a href="http://creativecommons.org/licenses/by-nc-nd/4.0/" target="_blank">http://creativecommons.org/licenses/by-nc-nd/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1080/20477724.2019.1639018" target="_blank">https://dx.doi.org/10.1080/20477724.2019.1639018</a></p>
Funding
Open Access funding provided by the Qatar National Library.
Qatar National Research Fund (NPRP- 5 - 098 – 3 - 021), Molecular Epidemiology of Malaria in India and Qatar with an Emphasis on Parasite Diversity, Drug Resistance and Immune Response.
This Item is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Institution affiliated with
Weill Cornell Medicine - Qatar
Hamad Medical Corporation
Hamad General Hospital - HMC
Ministry of Public Health
Related Datasets
Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar. Taylor & Francis. Bansal, Devendra; K. Bharti, Praveen; Acharya, Anushree; Abdelraheem, Mohamed H; Patel, Priyanka; Elmalik, Ashraf; et al.Figshare Repository. https://doi.org/10.6084/m9.figshare.8863445.v1
Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar. Taylor & Francis. Bansal, Devendra; Bharti, Praveen K.; Acharya, Anushree; Abdelraheem, Mohamed H; Patel, Priyanka; Elmalik, Ashraf; et al. Figshare Repository. https://doi.org/10.6084/m9.figshare.8863445.v2